Dr. Leapman on Factors Influencing the Decision to Undergo Genomic Testing in Prostate Cancer
February 23rd 2023Michael S. Leapman, MD, MHS, discusses key factors that influence patient experiences with biopsy-based genomic testing during active surveillance for prostate cancer, and how to best address them in clinical practice.